홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

Colfosceril Palmitate

HCID 452110
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
63-89-8
표준 SMILES
CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC
InChIKey
KILNVBDSWZSGLL-KXQOOQHDSA-N
분자식
C40H80NO8P
평균 분자량
734 g/mol
단동위원소 질량
733.56215551

개요

1,2-dihexadecanoyl-sn-glycero-3-phosphocholine is a phosphatidylcholine 32:0 in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl). A synthetic phospholipid used in liposomes and lipid bilayers to study biological membranes. It is also a major constituent of pulmonary surfactants. It has a role as a surfactant and a mouse metabolite. It is a phosphatidylcholine 32:0 and a 1-acyl-2-hexadecanoyl-sn-glycero-3-phosphocholine. It is functionally related to a hexadecanoic acid. It is a conjugate base of a 1,2-di-O-palmitoyl-sn-glycero-3-phosphocholine.

이름 및 식별자

우선 이름
Colfosceril Palmitate
IUPAC
[(2R)-2,3-di(hexadecanoyloxy)propyl] 2-(trimethylazaniumyl)ethyl phosphate
영어명
1,2-Dipalmitoyl-sn-glycero-3-phosphocholine
분자식
C40H80NO8P
분자량
734.04

이름 및 동의어

63-89-8Colfosceril palmitate1,2-Dipalmitoyl-sn-glycero-3-phosphocholinediPalmitoylphosphatidylcholinePalmitate de colfoscerilPalmitato de colfosceriloColfoscerili palmitas1,2-dihexadecanoyl-sn-glycero-3-phosphocholineColfoscerilDppc, l-Dppc, r-Dipalmitoyl lecithin, l-
이름 더 보기
DPPC1,2-dipalmitoyl-sn-glycero-3-PC16:0 PCDIPALMITOYL LECITHINL-A-LECITHIN DIPALMITOYLDIPALMITOYL-L-ALPHA-LECITHINB,G-DIPALMITOYL-L-A-LECITHINL-ALPHA-LECITHIN, DIPALMITOYL
DTXSID5046720129Y83319X2NFW0ADipalmitoyl glycerophosphocholine1-16:0-2-16:0-phosphatidylcholine[(2R)-2,3-di(hexadecanoyloxy)propyl] 2-(trimethylazaniumyl)ethyl phosphateSURFAXIN COMPONENT DPPCDTXCID3026720

데이터베이스 식별자

CAS
63-89-8
PubChem CID

물성

구조 계산 물성

XLogP
13.5
극성 표면적
111 Ų
수소 결합 공여자 수
0
수소 결합 수용자 수
8
회전 가능 결합 수
40
무거운 원자 수
50
형식 전하
0
복잡도
826

실험 및 물리화학적 성질

Lipids · 2건

Lipids -> Unambiguous Lipids

Lipids -> Glycerophospholipids [GP] -> Glycerophosphocholines [GP01] -> Diacylglycerophosphocholines [GP0101]

SolubilityVery poor solubility
Human Drugs · 2건

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Boiling Point60.5-61.5ºC at 760 mmHg
Melting Point-63ºC
Physical DescriptionSolid
Collision Cross Section · 2건

283.9 Ų [M+H]+ [CCS Type: DT; Buffer gas: N2; Sample Type: Human plasma; Dataset: Unambiguous Lipids]

281.91 Ų [M+H]+ [CCS Type: TIMS; Method: single field calibrated]

물리화학적 성질

녹는점
229 · 229-229.5 °C
저장 조건
-20 °C · -20°C
용해도
클로로포름(약간 용해됨), 메탄올(약간 용해됨)

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS ClassificationNot Classified

유해성 정보

Regulatory InformationColfosceril palmitate: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
Hazard Classes and CategoriesNot Classified

안전 데이터

wgk
3
HS 번호
29232000
safety_code
24/25
F 고인화성물질
10-21
스토리지 클래스
11 - Combustible Solids

화학 및 산업

약리 정보

ATC Code · 2건

R - Respiratory system

QR - Respiratory system

Protein BindingColfosceril palmitate stays and gets metabolized in the pulmunar tissue, thus it is not able to bind to plasma proteins.
Pharmacodynamics · 1건

Colfosceril palmitate has shown to significantly reduce the risk of pneumothoraces, pulmonary interstitial emphysema and mortality. Unlike naturals surfactants, colfosceril palmitate reduces the risk of bronchopulmonary dysplasia, intraventricular hemorrhage and patent ductus arteriosus. In clinical placebo-controlled trials, there was a significant reduction in the number of deaths attributed to hyaline membrane disease, the incidence of pulmonary air leaks, oxygen requirements and mean airway pressure. Some reports have indicated a lack of therapeutic effect due to the absence of surfactant protein.

Mechanism of Action · 1건

Treatment with colfosceril palmitate aims to reinflate a collapsed area of the lung, improve compliance and reduce intrapulmonary shunting. The actions of colfosceril palmitate are perfomed by replacing the defficient or innefective endogenous lung surfactant and thus, reducing the tension and stabilizing the alveoli from collapsing. Colfosceril palmitate will form a very thin film that will cover the surface of the alveolar cells and therefore it will reduce surface tension.

Biological Half-LifeThe half-life of colfosceril palmitate is registered to be in the range of 20-36 hours.
Metabolism/MetabolitesColfosceril palmitate is catabolized and reutilized for further synthesis and secretion in lung tissues.
Absorption, Distribution and Excretion · 4건

The absorption is done directly in the alveolus into the lung tissue. As the lung surfactant is distributed in the bronchi, bronchioles and alveoli, its highest concentration is at the alveolar air-fluid interface where it remains as a monolayer.

관련 반응

13건
반응 기록 만들기
HRID 37756 반응식
HRID 37756반응물로
HRID 230978 반응식
HRID 230978반응물로
HRID 230979 반응식
HRID 230979반응물로
HRID 230980 반응식
HRID 230980반응물로
HRID 399366 반응식
HRID 399366반응물로
HRID 481280 반응식
HRID 481280반응물로
HRID 1825693 반응식
HRID 1825693반응물로
HRID 1865764 반응식
HRID 1865764반응물로
이전1 / 2 페이지

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
452110
DTXSID
DTXSID5046720
ChEMBL
CHEMBL1200737
ChEBI
CHEBI:72999
UNII
319X2NFW0A
EC Number
200-567-6
Nikkaji
J110.766F
물리적 상태
고체
색상
흰색에서 황백색까지
생물학적 소스
synthetic
Merck
14 · 14,2477
안정성
안정적인. 강한 산화제와 호환되지 않습니다.
화장품 원료 기능
피부 컨디셔닝
InChIKey
KILNVBDSWZSGLL-KXQOOQHDSA-N
SMILES
[C@@H](OC(=O)CCCCCCCCCCCCCCC)(COC(=O)CCCCCCCCCCCCCCC)COP([O-])(=O)OCC[N+](C)(C)C |&1:0,r|

화학적 성질

white powder

After 5 days, most of the administered dose (56%) is distributed throughout the body with renal and fecal excretion being the minor elimination pathway representing the 4 and 2% of the eliminated dose respectively. The major route of elimination is by expelled air which accounts for 28% of the administered dose.

Colfosceril palmitate is distributed uniformly to all lobes of the lung, distal airways and alveolar spaces. It will not enter the systemic circulation in healthy lungs, however when the integrity of the tissue is distrupted colfosceril can reach systemic circulation. Even 5 days after administration, there are traces of colfosceril palmitate retained in the body that represented 72% of the administered dose which by then have entered pathways of lipid metabolism to become tissue associated.

After 5 days of drug administration, the lung and liver would contain 10% of the administered dose and the elimination via renal excretion accounts only for 8% of the administered dose. This proved a very small renal clearance and confirmed that the major elimination route is by expired air.

Tissue LocationsPlacenta
Cellular LocationsCytoplasm
Metabolite PathwaysPhosphatidylcholine Biosynthesis PC(16:0/16:0)
응용 분야 · 2건

용도1,2-dipalmitoyl-sn-glycero-3-phosphocholine is a major phospholipid constituent and primary surface tension lowering component of natural lung surfactant. Colfosceril Palmitate is used as pulmonary surfactant and diagnostic aid (fetal lung maturity).

일반 설명1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine is a strong bilayer-forming lipid. It the most common phospholipid in mammalian membranes. It is also an important component of the mucosal layer of the colon.

상·하류 제품 정보

상류 원료

TYLOXAPOLHexadecanoic acid, 1,1'-[1-[[(2-oxido-1,3,2-dioxaphospholan-2-yl)oxy]methyl]-1,2-ethanediyl] ester[S,(+)]-1-O,2-O-디팔미토일-3-O-트리틸-L-글리세롤2-클로로에틸인산이염화물글리세로포스포콜린1,2-DIPALMITOYL-SN-글리세롤콜린토실레이트파미틴 산트라이메틸아민(트리메틸아민)

하류 제품

1,2-디팔미토일-SN-글리세로-3-포스포부탄올(나트륨염)
추가 설명 · 1건

정의ChEBI: A phosphatidylcholine 32:0 in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl). A synthetic phospholipid used in liposomes and lipid bilayers to study biological membranes. It is also a major constituent of pulmonary surfactants.